Blog Archives

New Malaria Target: Blocking Protein Transport

The lifecycle of all Plasmodium species is complex and involves a round of replication in host erythrocytes. The clinical manifestations of malaria are linked to this stage in the lifecycle and are associated with rupture of the infected erythrocytes. During

Tagged with: , ,
Posted in News

Battle of the Bulge

An aortic aneurysm is a bulge in the aorta, the largest blood vessel in the body, which results from weakening of the artery wall. The majority of these occur in the portion of the aorta that passes through the abdomen

Tagged with: , ,
Posted in News

Protease Inhibitor Treats Rare Genetic Brain Disorder

Lissencephaly (literally “smooth brain”) describes a set of rare conditions in which the foetal brain does not develop normally beyond the third or fourth month of pregnancy and, instead of the usual folds and grooves, the cerebrum has a partially

Tagged with: ,
Posted in News

Small Molecule Inhibitors of Kaposi’s Sarcoma Virus Protease

Kaposi’s sarcoma (KS) is caused by Kaposi sarcoma herpes virus (KSHV) which is also known as human herpes virus 8 (HHV8). HHV8 infection rates vary widely amongst different populations but KS rarely develops unless the immune system is compromised, by

Tagged with: , ,
Posted in News

Protease Inhibitors Could Be Effective For Fungal Disease

Chromoblastomycosis is a chronic fungal infection of the skin and subcutaneous tissue most commonly caused by infection with Fonsecaea pedrosoi. The disease occurs most often in rural areas in tropical and subtropical countries and is caused when fungus is introduced

Tagged with: ,
Posted in News